Please login to the form below
Acquisition
This page shows the latest Acquisition news and features for those working in and with pharma, biotech and healthcare.
Gilead agrees $21bn buyout of Immunomedics
Following the acquisition, Gilead gains rights to Immunomedics antibody-drug conjugate (ADC) Trodelvy (sacituzumab govitecan-hziy), which was approved by the US Food and Drug Administration (FDA) in April for the ... This acquisition represents
Latest news
-
Nestlé is set to acquire Aimmune in deal worth $2.6bn
This acquisition ensures a level of support for Palforzia and our pipeline that will further enhance their potential for patients around the world who are living with food allergies,” said Jayson
-
Takeda to sell Japan consumer health unit for $2.3bn
As well as completing $10bn in divestment transactions, Takeda has made other sacrifices for the Shire acquisition, including the sale of its Osaka headquarters in July 2018.
-
J&J inks $6.5bn all-cash deal to acquire Momenta
Acquisition sees J&J gain access to portfolio of autoimmune disease treatments.
-
Sanofi bolsters pipeline with $3.7bn deal for Principia Biopharma
The lead candidate, and focus of the acquisition, is BTK inhibitor ‘168, currently in development for the treatment of multiple sclerosis (MS). ... The addition of multiple BTK inhibitors to our pipeline demonstrates our commitment to strategic product
-
Calliditas bets on PBC drug in Genkyotex buyout
The company will then seek to acquire all outstanding Genkyotex shares, with a total acquisition cost of approximately 32.2m as well as up to 55m in contingent rights.
More from news
Approximately 198 fully matching, plus 1,210 partially matching documents found.
Latest Intelligence
-
AI: the smart money is on the smart thinking
Recognising this, big pharma firms are already looking to consolidate with AI solutions, if not through acquisitions, then through partnerships. ... Indeed, this has been evidenced recently by Thermo Fisher’s acquisition of Qiagen in May for $11.5bn.
-
Gut instincts lead Takeda to GI pipeline success
Parikh has good reason to celebrate, as he has been involved in constructing a potent GI unit that took its first steps with Takeda’s 2008 acquisition of US biotechnology company ... We are completely focused on helping them.”. The GI building
-
The impact of COVID-19 on clinical trials
Many with promising and potentially high-value platforms may be at risk of acquisition from larger companies based on unfavourable terms. ... Acquisitions might present the opportunity for larger companies to expand their pipelines with additional assets
-
Pharma funding and M&A in 2020
traditional pharmaceutical companies look to increase innovation is through bolt-on acquisitions of more innovative players in the industry. ... But such bolt-on acquisitions are not just beneficial to Big Pharma – they can also benefit smaller firms.
-
20 for 2020 – Five pharma leaders to watch in 2020
That new strategy was thrown into relief by Sanofi’s acquisition of cancer specialist Synthorx, announced in December 2019 and completed in January 2020, the first major deal under Hudson’s
More from intelligence
Approximately 74 fully matching, plus 89 partially matching documents found.
Latest appointments
-
New hires at FibroGen, Saniona and Turbine
In that role, Barge oversaw the company’s acquisition of Kudos, which yielded the drug Lynparza (olaparib).
-
New hires at Bristol-Myers Squibb, Acceleron and FerGene
Metcalfe joins BMS from CVS Health, where she led communications following the company’s acquisition of Aetna, where she was chief communication officer.
-
New hires at Abbott, Kite and Arrakis Therapeutics
Jude Medical – Abbott’s largest acquisition. He also led Abbott’s Diabetes Care business and the launch of the FreeStyle Libre. ... Most recently, Bosley served as the chief executive officer of Editas Medicine, and previously worked as CEO of
-
New hires at Bayer, Eisai and Accord Healthcare
Marianne De Backer is a recognised business leader with an impressive track record spanning over two decades in research and commercial, as well as licensing, mergers and acquisitions,” said Stefan Oelrich,
-
Lucid Group announces new hires at its creative and digital agency Bluedog
The move was Lucid Group’s first major acquisition, and came as the group celebrated its 12-year anniversary.
More from appointments
Approximately 0 fully matching, plus 119 partially matching documents found.
Latest from PMHub
-
Virtual Engagement At Porterhouse: Reflections on the past few months
adapt to the virtual environment as a matter of necessity; this has instigated rapid acquisition of a skill set that can be used during the COVID-19 pandemic and beyond.
-
Taking the ‘free’ out of ‘freelance’ and bringing it in-house
Contact Dan Newbury, Talent Acquisition Manager. Email: daniel@lucid-group.co.uk. Tel: 07584 575260.
-
Fishawack Health adds market access and commercial strategy consultancy Skysis as part of its bold growth plans
Fishawack Health, the global healthcare communications agency, announces the acquisition of Skysis, a boutique consulting firm providing integrated market access and commercial strategy solutions based in the US. ... The acquisition bolsters our strong
-
90TEN acquired by Envision Pharma Group
In adding 90TEN’s strengths in behavioral science, creativity, and insight-driven communications, this acquisition will deliver an enhanced service offering to the Group’s global client base. ... The acquisition of 90TEN will bring the total number
-
For those who love science and storytelling — consider medical writing
way to opportunities for career development and skills acquisition in both writing and project management that I wasn’t even aware existed. ... Contact Dan Newbury, Talent Acquisition Manager. Email: daniel@lucid-group.co.uk. Tel: 07584 575260.
More from PMHub
Approximately 9 fully matching, plus 71 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Gilead agrees $21bn buyout of Immunomedics
- Regeneron launches phase 3 COVID-19 antibody trial in the UK
- Regeneron launches phase 3 COVID-19 antibody trial in the UK
- Gavi says 76 wealthy countries have committed to COVAX vaccine facility
- Roche’s Ocrevus boasts positive long-term data in MS
- First patients dosed with COVID-19 vaccine from SpyBiotech and Serum Institute of India
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Envision Pharma Group scoops two Silvers at the PM Society Digital Awards 2020
- Alone we can do so little, together we can do so much
- What can't we afford to treat anymore?
- OPEN VIE is awarded a Bronze Award at the PM Society Digital Awards 2020
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
PMHub
KVA Digital
KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...
Latest intelligence
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
- Alone we can do so little, together we can do so much
- Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
- 7 important considerations for creating an inclusive clinical trial website
- You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
Quick links
Infographics
